Parents who resort to using cannabis products to control treatment-resistant epilepsy in children perceive benefits that are not matched by objective results, an Australian-led study has found. A survey of 312 caregivers of children with CDKL5 Deficiency Disorder (CDD) early-onset epilepsy found that one in four (26%) reported current or previous use of cannabis products ...
Perceptions of cannabis benefits in epilepsy not matched by objective results
By Michael Woodhead
24 Jun 2021